These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34383967)

  • 1. Naloxone prescribing to older adults in primary care.
    Luther CD; Hughes TD; Ferreri SP
    J Am Geriatr Soc; 2021 Dec; 69(12):3681-3683. PubMed ID: 34383967
    [No Abstract]   [Full Text] [Related]  

  • 2. Should we be routinely co-prescribing naloxone for patients on long term opioids?
    Prathivadi P; Nielsen S
    Med J Aust; 2021 May; 214(9):403-404.e1. PubMed ID: 33895991
    [No Abstract]   [Full Text] [Related]  

  • 3. Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.
    Park TW; Bohnert AS; Austin KL; Saitz R; Pizer SD
    Psychiatr Serv; 2014 Jan; 65(1):4. PubMed ID: 24382761
    [No Abstract]   [Full Text] [Related]  

  • 4. Naloxone Co-prescribing to Patients Receiving Prescription Opioids in the Medicare Part D Program, United States, 2016-2017.
    Jones CM; Compton W; Vythilingam M; Giroir B
    JAMA; 2019 Aug; 322(5):462-464. PubMed ID: 31386124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone-Prescribing Practices: A Missed Opportunity.
    Stone S; Barnes E; McLouth CJ; McNeil CJ
    N C Med J; 2018; 79(5):343-344. PubMed ID: 30228147
    [No Abstract]   [Full Text] [Related]  

  • 6. Association Between a State Law Allowing Pharmacists to Dispense Naloxone Without a Prescription and Naloxone Dispensing Rates.
    Gangal NS; Hincapie AL; Jandarov R; Frede SM; Boone JM; MacKinnon NJ; Koechlin K; DeFiore-Hyrmer J; Holthusen A; Heaton PC
    JAMA Netw Open; 2020 Jan; 3(1):e1920310. PubMed ID: 32003819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone Dispensing to Youth Ages 10-19: 2017-2022.
    Terranella A; Guy G; Mikosz C
    Pediatrics; 2024 Oct; 154(4):. PubMed ID: 39262344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.
    Stein BD; Saloner B; Schuler MS; Gurvey J; Sorbero M; Gordon AJ
    JAMA; 2021 Jun; 325(21):2206-2208. PubMed ID: 34061152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study.
    Johnson CF; Frei C; Downes N; McTaggart SA; Akram G
    Br J Gen Pract; 2016 Jun; 66(647):e410-5. PubMed ID: 27114208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic.
    Nguyen TD; Gupta S; Ziedan E; Simon KI; Alexander GC; Saloner B; Stein BD
    JAMA Intern Med; 2021 Apr; 181(4):562-565. PubMed ID: 33346795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing information systems; making sense of primary care data.
    Chapman SR
    J Clin Pharm Ther; 2001 Aug; 26(4):235-9. PubMed ID: 11493364
    [No Abstract]   [Full Text] [Related]  

  • 12. Retrospective study investigating naloxone prescribing and cost in US Medicaid and Medicare patients.
    Manko CD; Ahmed MS; Harrison LR; Kodavatiganti SA; Lugo N; Konadu JO; Khan F; Massari CA; Sealey TK; Addison ME; Mbah CN; McCall KL; Fraiman JB; Piper BJ
    BMJ Open; 2024 May; 14(5):e078592. PubMed ID: 38692729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration.
    Bounthavong M; Devine EB; Christopher MLD; Harvey MA; Veenstra DL; Basu A
    Health Serv Res; 2019 Oct; 54(5):1055-1064. PubMed ID: 31313839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns in Outpatient Benzodiazepine Prescribing in the United States.
    Agarwal SD; Landon BE
    JAMA Netw Open; 2019 Jan; 2(1):e187399. PubMed ID: 30681713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of psychiatrists' prescription of opioid, benzodiazepine, and buprenorphine in Medicare Part D in the United States.
    Pan K; Silver S; Davis C
    Trends Psychiatry Psychother; 2020; 42(1):48-54. PubMed ID: 32321084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.
    Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE
    Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combatting Opioid Overdoses in Ohio: Emergency Department Physicians' Prescribing Patterns and Perceptions of Naloxone.
    Penm J; MacKinnon NJ; Lyons MS; Tolle E; Sneed GT
    J Gen Intern Med; 2018 May; 33(5):608-609. PubMed ID: 29492780
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescribing practices of rural primary health care physicians in Uzbekistan.
    Pavin M; Nurgozhin T; Hafner G; Yusufy F; Laing R
    Trop Med Int Health; 2003 Feb; 8(2):182-90. PubMed ID: 12581446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada.
    Tu K; Mamdani MM; Hux JE; Tu JB
    J Am Geriatr Soc; 2001 Oct; 49(10):1341-5. PubMed ID: 11890493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing use of opioids for pain.
    Fredheim OM
    Eur J Pain; 2014 Oct; 18(9):1219-20. PubMed ID: 25195682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.